Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Increased Survival and Reversion of Iron-Induced Cardiac Disease in Patients With Thalassemia Major Receiving Intensive Combined Chelation Therapy

NCT00800761 is registered in ClinicalTrials.gov with Ospedale Microcitemico as lead sponsor.

NCT NCT00800761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00800761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Increased Survival and Reversion of Iron-Induced Cardiac Disease in Patients With Thalassemia Major Receiving Intensive Combined Chelation Therapy
Lead sponsor
Ospedale Microcitemico
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2001
Completion date
June 30, 2006
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, iron overload